Equitable Holdings Appoints Douglas Dachille to the Board of Directors
Equitable Holdings (NYSE: EQH) has appointed Douglas Dachille as an independent member of its Board of Directors, effective immediately. Dachille brings three decades of expertise in insurance, banking, and asset management industries. He previously served as Chief Investment Officer of AIG from 2015 to 2021, managing a $350 billion portfolio and playing a important role in the company's post-financial crisis recovery.
Prior to AIG, Dachille co-founded and led First Principles Capital Management, served as President and COO of Zurich Capital Markets, and held leadership positions at JPMorgan Chase, including Global Head of Proprietary Trading and Co-Treasurer. He currently serves on the BridgeBio Pharma Board of Directors and holds an MBA from the University of Chicago.
Equitable Holdings (NYSE: EQH) ha nominato Douglas Dachille come membro indipendente del suo Consiglio di Amministrazione, con effetto immediato. Dachille porta con sé tre decenni di esperienza nei settori assicurativo, bancario e della gestione patrimoniale. In precedenza, ha ricoperto il ruolo di Chief Investment Officer di AIG dal 2015 al 2021, gestendo un portafoglio di 350 miliardi di dollari e contribuendo in modo significativo alla ripresa dell'azienda dopo la crisi finanziaria.
Prima di unirsi ad AIG, Dachille ha co-fondato e guidato First Principles Capital Management, è stato Presidente e COO di Zurich Capital Markets, e ha ricoperto ruoli di leadership in JPMorgan Chase, inclusa la posizione di Global Head of Proprietary Trading e Co-Treasurer. Attualmente fa parte del Consiglio di Amministrazione di BridgeBio Pharma e possiede un MBA della University of Chicago.
Equitable Holdings (NYSE: EQH) ha nombrado a Douglas Dachille como miembro independiente de su Junta Directiva, con efecto inmediato. Dachille aporta tres décadas de experiencia en los sectores de seguros, banca y gestión de activos. Anteriormente, se desempeñó como Chief Investment Officer de AIG desde 2015 hasta 2021, gestionando un portafolio de 350 mil millones de dólares y desempeñando un papel importante en la recuperación de la empresa tras la crisis financiera.
Antes de unirse a AIG, Dachille cofundó y lideró First Principles Capital Management, fue Presidente y COO de Zurich Capital Markets, y ocupó cargos de liderazgo en JPMorgan Chase, incluyendo el de Global Head of Proprietary Trading y Co-Treasurer. Actualmente forma parte de la Junta Directiva de BridgeBio Pharma y posee un MBA de la Universidad de Chicago.
Equitable Holdings (NYSE: EQH)가 독립 이사로 더글라스 다치레 (Douglas Dachille)을 즉시 발탁했습니다. 다치레는 보험, 은행 및 자산 관리 산업에서 30년 이상의 경험을 가지고 있습니다. 그는 2015년부터 2021년까지 AIG의 최고 투자 책임자 역할을 맡으며 3,500억 달러 규모의 포트폴리오를 관리하고 금융 위기 이후 회사의 회복에 중요한 역할을 했습니다.
AIG 이전에는 다치레가 First Principles Capital Management를 공동 출시 및 이끌었으며, Zurich Capital Markets의 사장 및 COO로 재직했고, JPMorgan Chase에서 글로벌 자산 거래 책임자 및 공동 재무 책임자와 같은 리더십 역할을 수행했습니다. 그는 현재 BridgeBio Pharma의 이사회에서 활동하고 있으며, 시카고 대학교에서 MBA를 취득했습니다.
Equitable Holdings (NYSE: EQH) a nommé Douglas Dachille en tant que membre indépendant de son Conseil d'Administration, avec effet immédiat. Dachille apporte trois décennies d'expertise dans les secteurs de l'assurance, de la banque et de la gestion d'actifs. Il a précédemment exercé la fonction de Chief Investment Officer d'AIG de 2015 à 2021, gérant un portefeuille de 350 milliards de dollars et jouant un rôle essentiel dans la reprise de l'entreprise après la crise financière.
Avant de rejoindre AIG, Dachille a cofondé et dirigé First Principles Capital Management, a été président et COO de Zurich Capital Markets, et a occupé des postes de direction chez JPMorgan Chase, y compris celui de Global Head of Proprietary Trading et Co-Treasurer. Il est actuellement membre du Conseil d'Administration de BridgeBio Pharma et détient un MBA de l'Université de Chicago.
Equitable Holdings (NYSE: EQH) hat Douglas Dachille zu einem unabhängigen Mitglied seines Verwaltungsrats ernannt, mit sofortiger Wirkung. Dachille bringt drei Jahrzehnte Erfahrung in den Bereichen Versicherung, Bankwesen und Vermögensverwaltung mit. Zuvor war er von 2015 bis 2021 Chief Investment Officer von AIG und verwaltete ein Portfolio im Wert von 350 Milliarden Dollar und spielte eine wichtige Rolle bei der Erholung des Unternehmens nach der Finanzkrise.
Vor AIG war Dachille Mitbegründer und Leiter von First Principles Capital Management, Präsident und COO von Zurich Capital Markets und hatte Führungspositionen bei JPMorgan Chase inne, darunter Global Head of Proprietary Trading und Co-Treasurer. Er ist derzeit Mitglied des Vorstands von BridgeBio Pharma und hat einen MBA der University of Chicago.
- Appointment brings extensive experience in managing large-scale portfolios ($350 billion at AIG)
- Strong background in corporate transactions and capital markets
- Proven track record in stabilizing financial institutions post-crisis
- Expertise across integrated advice, retirement, and asset management sectors
- None.
Mr. Dachille has amassed a distinguished career across three decades with proven expertise in the most strategic matters facing the insurance, banking and asset management industries. This includes leading complex corporate transactions, understanding capital markets and designing innovative investment solutions to meet insurance liabilities.
“On behalf of the Board of Directors, I am delighted to welcome Doug Dachille to Equitable Holdings,” said Joan Lamm-Tennant, Chair of the Equitable Holdings Board of Directors. “His experience leading insurance and asset management organizations will be instrumental as we continue to enhance the company’s value and navigate the evolving industry and macro-economic environment.”
Mr. Dachille served as Chief Investment Officer of American International Group Inc. (AIG) from 2015 until 2021, overseeing a
“Doug brings to us relevant experience across our integrated advice, retirement and asset management businesses,” said Mark Pearson, President and Chief Executive Officer of Equitable Holdings. “His unparalleled industry perspective will help guide us as we continue to deliver on our financial commitments, grow our businesses and create value for our shareholders.”
Mr. Dachille currently serves as an independent director of the BridgeBio Pharma, Inc. Board of Directors and previously served on the board of directors for Lyndra Therapeutics®. He earned a Bachelor of Science degree from Union University through a joint program with Albany Medical College, and later earned an MBA from the University of
About Equitable Holdings:
Equitable Holdings, Inc. (NYSE: EQH) is a leading financial services holding company comprised of complementary and well-established businesses, Equitable, AllianceBernstein and Equitable Advisors. Equitable Holdings has
* Securities and investment advisory products and services offered through Equitable Advisors, LLC (member FINRA, SIPC), a broker-dealer and SEC-registered investment advisor; insurance and annuities offered through Equitable Network, LLC. Reference to the 1859 founding applies specifically and exclusively to Equitable Financial Life Insurance Company (Equitable Financial) (NY, NY).
View source version on businesswire.com: https://www.businesswire.com/news/home/20250115470700/en/
Investor Relations
Erik Bass
(212) 314-2476
IR@equitable.com
Media Relations
Laura Yagerman
(212) 314-2010
mediarelations@equitable.com
Source: Equitable Holdings, Inc.
FAQ
What experience does Douglas Dachille bring to Equitable Holdings (EQH) board?
When did Douglas Dachille join Equitable Holdings (EQH) board?
What was Douglas Dachille's role at AIG before joining EQH?
How will Douglas Dachille's appointment benefit EQH shareholders?
